Science FDA (and everyone else) needs to actively engage as they think about whether to authorize Juul and the other ecigs

When I read the FDA’s Technical Project Lead summary of its scientific justification for authorizing the sale of RJ Reynolds’ Vuse Solo e-cigarette, I was struck by the fact that it ignored the broad scientific literature on e-cigarettes and seemed to accept industry-framed arguments. For example: They ignored the evidence that as consumer products, e-cigarettesContinue reading “Science FDA (and everyone else) needs to actively engage as they think about whether to authorize Juul and the other ecigs”

PM’s modified risk tobacco product application for IQOS 3 ignores new published research on toxic emissions in IQOS aerosol and does not demonstrate benefits to individual or population health; FDA should deny its application to make reduced exposure claims

My UCSF TCORS colleagues and I submitted this public comment to the FDA opposing Philip Morris’ application for authorization for them to make modified risk claims for its new IQOS 3 heated tobacco product. A PDF of the comment is here. The Regulations.gov tracking number is kur-iypq-uf1v. Here is the comment: The supplemental modified riskContinue reading “PM’s modified risk tobacco product application for IQOS 3 ignores new published research on toxic emissions in IQOS aerosol and does not demonstrate benefits to individual or population health; FDA should deny its application to make reduced exposure claims”

“Big Vape” is well worth reading

As I said in my review of Lauren Etter’s history of Juul, The Devil’s Playbook, my definition of a good book on tobacco is that I learn things I didn’t already know from reading it. Even after reading Etter’s book, Jamie Ducharme’s Big Vape is a good book. While all the key major events appearContinue reading ““Big Vape” is well worth reading”

Menthol: Two wrongs won’t make a right

After refusing to authorize the sale of over a million e-cigarette flavors, the FDA still has not dealt with menthol (or tobacco flavored) e-cigarettes. As detailed in an earlier blog post, I remain concerned that FDA will authorize the sale of menthol e-cigarettes using the incorrect logic that menthol e-cigarettes need to remain available asContinue reading “Menthol: Two wrongs won’t make a right”

No quitting benefit for e-cigs over FDA-approved therapies … and lots of dangerous dual use

The FDA Center for Tobacco Products concern about balancing potential benefits of e-cigs with demonstrated risks to youth presumes that adults using e-cigarettes will switch completely to e-cigs and that e-cigs are substantially less risky than cigarettes. Bekir Kaplan and colleagues’ new paper Effectiveness of ENDS, NRT and medication for smoking cessation among cigarette-only users:Continue reading “No quitting benefit for e-cigs over FDA-approved therapies … and lots of dangerous dual use”

“Move Fast and Vape Things” is worth watching

The New York Times just released its new one hour documentary on the origins of Juul, Move Fast and Vape Things. (You can watch a trailer and some clips from the film and link to Hulu, where the full film is available, here.) The film includes interviews with an addicted teen, the two men whoContinue reading ““Move Fast and Vape Things” is worth watching”

FDA denied over 1 million e-cig flavored products but not a single one with menthol

Despite the fact that menthol and mint are wildly popular with kids (and contribute to keeping adults addicted), the FDA Center for Tobacco Products has yet to prohibit the sale of a single menthol e-cigarette flavor. The CTP News sent out today reported: FDA Denies Marketing Applications for Over 1 Million Flavored E-Cigarette ProductsIn August,Continue reading “FDA denied over 1 million e-cig flavored products but not a single one with menthol”